Clinical Trial Update: A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating infliximab for psoriasis has completed, reporting safety and efficacy findings in this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED